Pilot Study of the Effect of Ultraviolet Light on Pain and Mood in Fibromyalgia Syndrome

Pilot Study of the Effect of Ultraviolet Light on Pain and Mood in Fibromyalgia Syndrome
复制标题

DOI:
10.1089/acm.2008.0167
复制
发表时间:
2009-01-01
影响因子:
2.6
通讯作者:
Feldman, Steven R.
Feldman, Steven R.
中科院分区:
医学4区
文献类型:
--
作者:
Taylor, Sarah L.;Kaur, Mandeep;Feldman, Steven R.

文献摘要

被引文献

相似文献

背景:纤维肌痛综合征(FMS)相关疼痛缺乏有效的系统性或充分的对症治疗。坊间传闻紫外线(UV)可能有一些好处。目的:本研究的目的是确定UV是否有效地改善FMS患者的慢性疼痛。方法:19名FMS受试者加入紫外线和非紫外线(对照)晒黑床的对照试验,为期2周,然后随机分组,接受紫外线或非紫外线(对照)照射,再持续6周。最后一次治疗后4周随访。采用11分数值疼痛评分(Likert量表)、视觉模拟疼痛量表(VAS)和McGill疼痛问卷来评估疼痛。情绪变量也被评估。结果:在受试者接受紫外线和非紫外线(对照)暴露的最初2周内,暴露于紫外线后的11分李克特疼痛评分比暴露前水平下降0.44分(标准差= 0.095)。此外,与非紫外线(对照)暴露相比,紫外线暴露会产生更大的积极影响、幸福感、放松和疼痛水平降低(优势比[OR] = 2.80, p = 0.0059)。随机治疗期后,根据McGill疼痛问卷测量,紫外线组与非紫外线组相比疼痛有轻微改善(12.2 vs 14.1, p = 0.049);其他疼痛量表的结果不显著。最后一次治疗后4周的评估显示,在调整后的结果平均得分上没有显著差异。结论:这项初步研究的结果表明,晒黑床可能在减轻FMS患者疼痛方面具有一定的潜力。
Background: There is a lack of effective systemic or adequate symptomatic treatment for pain associated with fibromyalgia syndrome (FMS). Anecdotes suggest ultraviolet (UV) light may be of some benefit.Purpose: The purpose of the present study was to determine if UV is effective in ameliorating chronic pain in persons with FMS.Methods: Nineteen subjects with FMS were enrolled in a controlled trial of UV and non-UV (control) tanning beds for 2 weeks, followed by randomization to receive UV or non-UV (control) exposure for 6 additional weeks. A follow-up interview was conducted 4 weeks after the last treatment. Pain was assessed with an 11-point numerical pain rating (Likert scale), a visual analogue pain scale (VAS), and the McGill Pain Questionnaire. Mood variables were also assessed.Results: During the initial 2 weeks when subjects received both UV and non-UV (control) exposures, the 11-point Likert scale pain score decreased 0.44 points after exposure to UV from pre-exposure levels (S. E. = .095). Additionally, UV exposure resulted in greater positive affect, well-being, relaxation, and reduced pain levels when compared to non-UV (control) exposure (Odds Ratio [OR] = 2.80, p = 0.0059). Following the randomized treatment period, there was slight improvement in pain as measured by the McGill Pain Questionnaire in the UV group compared to the non-UV (control) group (12.2 versus 14.1; p = 0.049); the other pain scales yielded nonsignificant results. Assessment 4 weeks after the last treatment showed no significant differences in scores in the adjusted means for outcomes.Conclusions: Results from this pilot study suggest that tanning beds may have some potential in reducing pain in persons with FMS.